Trending...
- Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
- Naperville: Downtown Parking Survey Open Until July 27
- Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio
CHICAGO - illiNews -- The American Gastroenterological Association, founded in 1897 and widely regarded as the leading voice for gastroenterology professionals worldwide, has unveiled the inaugural class of its new incubator program, called "Improving GI Care," created in partnership with the healthcare innovation hub MATTER.
Selection into this cohort represents formal recognition from one of the field's most established medical societies that a startup's technology addresses a genuine, unmet need within digestive disease care. Eleven companies earned spots in this first-ever cohort, chosen from a competitive pool of applicants after a rigorous, multi-stage evaluation process.
Over six months, these startups will receive mentorship, strategic guidance, and access to MATTER's network of healthcare industry connections, culminating in a showcase event at Digestive Disease Week 2026 in Chicago, where they'll present progress to investors and potential partners.
Among the eleven selected startups is Neurogut, developer of the BioAnatoner System, a clinically validated biofeedback therapy device built to address major pelvic floor disorders. The device targets conditions including dyssynergic defecation (a common form of chronic constipation), along with both fecal and urinary incontinence. What distinguishes the BioAnatoner from competing solutions is its dual-use design: the system functions equally well in clinical settings and in patients' homes.
More on illi News
Given that pelvic floor disorders affect more than 100 million Americans yet remain chronically underserved by existing therapies, Neurogut's platform is positioned to fill a significant gap. Company leadership has indicated plans to bring the BioAnatoner to market during 2026, with an initial focus on scaling distribution across clinical networks before pursuing broader consumer accessibility.
Neurogut's clinical direction has benefited from guidance provided by Dr. Satish Rao, a professor of medicine at Augusta University who has spent decades researching anorectal disorders, motility, and biofeedback-based treatments. Dr. Rao is widely credited with pioneering biofeedback therapy techniques for dyssynergic defecation, and his research contributions have earned him multiple honors from the AGA itself, including its Distinguished Clinician Award and Masters Award for Outstanding Clinical Research.
His advisory involvement extends beyond Neurogut. He also serves as a scientific advisor for GI Transit, another company within this incubator cohort that is developing bionic diagnostic devices for the upper gastrointestinal tract. Having a researcher of Dr. Rao's caliber connected to multiple companies in the same cohort speaks to the depth of clinical expertise informing this year's selected startups, and underscores how closely academic gastroenterology and early-stage medical technology are now intertwined.
More on illi News
As the incubator program progresses toward its culmination next spring, Neurogut and its cohort peers will continue refining their offerings with support from AGA and MATTER's combined resources, working toward the shared goal of transforming digestive disease care for millions of patients nationwide.
Learn more at https://www.neurogut.com
Selection into this cohort represents formal recognition from one of the field's most established medical societies that a startup's technology addresses a genuine, unmet need within digestive disease care. Eleven companies earned spots in this first-ever cohort, chosen from a competitive pool of applicants after a rigorous, multi-stage evaluation process.
Over six months, these startups will receive mentorship, strategic guidance, and access to MATTER's network of healthcare industry connections, culminating in a showcase event at Digestive Disease Week 2026 in Chicago, where they'll present progress to investors and potential partners.
Among the eleven selected startups is Neurogut, developer of the BioAnatoner System, a clinically validated biofeedback therapy device built to address major pelvic floor disorders. The device targets conditions including dyssynergic defecation (a common form of chronic constipation), along with both fecal and urinary incontinence. What distinguishes the BioAnatoner from competing solutions is its dual-use design: the system functions equally well in clinical settings and in patients' homes.
More on illi News
- Heidi G. Villari of The Villari Firm, PLLC Named to Super Lawyers for the Tenth Consecutive Year
- Naperville to Celebrate National Night Out with Community Events on Aug. 3 and 4
- Chris The Wiz Releases Can't Tell EP
- Elevate Your Sneakers With Crep Protect Trek Laces
- Meet Privateer: Tucson's High-Tech Security Force Built With Paramilitary Precision
Given that pelvic floor disorders affect more than 100 million Americans yet remain chronically underserved by existing therapies, Neurogut's platform is positioned to fill a significant gap. Company leadership has indicated plans to bring the BioAnatoner to market during 2026, with an initial focus on scaling distribution across clinical networks before pursuing broader consumer accessibility.
Neurogut's clinical direction has benefited from guidance provided by Dr. Satish Rao, a professor of medicine at Augusta University who has spent decades researching anorectal disorders, motility, and biofeedback-based treatments. Dr. Rao is widely credited with pioneering biofeedback therapy techniques for dyssynergic defecation, and his research contributions have earned him multiple honors from the AGA itself, including its Distinguished Clinician Award and Masters Award for Outstanding Clinical Research.
His advisory involvement extends beyond Neurogut. He also serves as a scientific advisor for GI Transit, another company within this incubator cohort that is developing bionic diagnostic devices for the upper gastrointestinal tract. Having a researcher of Dr. Rao's caliber connected to multiple companies in the same cohort speaks to the depth of clinical expertise informing this year's selected startups, and underscores how closely academic gastroenterology and early-stage medical technology are now intertwined.
More on illi News
- Axis International Presents Innovative Spoon Rest with Hinged Lid for Licensing Opportunities
- Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
- Sunny The Sandman Brings Coastal Charm and Seasonal Decorating Together in One Illuminated Home Décor Concept
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
- Body-Solid Launches the GSFR100 All-In-One Functional Trainer/Smith Machine
As the incubator program progresses toward its culmination next spring, Neurogut and its cohort peers will continue refining their offerings with support from AGA and MATTER's combined resources, working toward the shared goal of transforming digestive disease care for millions of patients nationwide.
Learn more at https://www.neurogut.com
Source: Neurogut
0 Comments
Latest on illi News
- Grab-Tab Technology™ Introduces a Smarter Way to Use Tape
- Marcus Christ Announces Singles: "The Hammer Goes Click" and "You Hate Me, I Hate You"
- Fatal FOMO May be Your Last Roll of the Dice
- Chicago is Invited to "Get Your Kicks in Bronzeville™
- Book 'Elephants In The Room' Published by Speaking Volumes
- Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
- Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio
- Naperville: Downtown Parking Survey Open Until July 27
- Chicago: Mayor Brandon Johnson, Community Leaders Cut Ribbon on Grand Boulevard Office Project the Estate Escape
- City of Chicago Encourages Individuals Identified in the Illinois Accountability Commission Report to Come Forward as an Independent Review Moves Forward
- Chicago: Mayor Brandon Johnson Joins CREATE Program and Partners to Break Ground on Columbus Ave Rail Grade Separation Project (GS11)
- Chicago: Mayor Bradnon Johnson, Department of Business Affairs and Consumer Protection Honors Graduates of Business Education Program
- Mayor Brandon Johnson and DCASE Award More Than $1.3 Million to Chicago Artists Through 2026 Individual Artists Program Grants
- PokerStars & Ladbrokes veteran buys into Finnish news media Rahapelisanomat
- Former Judge Chris Oldner Honored as Best Lawyer by "D Magazine" for 6th Straight Year
- Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641
- Naperville Police Accepting Applications for Fall 2026 Citizen Police Academy
- Naperville's Retail, Financial Landscape Among the Best in the State
- Naperville: Structure Fire in the 200 Block of Cedarbrook Road
- Boston Industrial Solutions Launches New Citrine® SA1-370 Silicone Glue for Permanent Adhesion